HSP90亚型在皮肤炎症中的差异作用:TRAP1抑制的抗炎潜力
本研究在刺激后的角质形成细胞中分别敲低4种HSP90亚型(HSP90α、HSP90β、GRP94、TRAP1),发现TRAP1敲低显著下调所测炎症基因表达,而HSP90α/β敲低呈炎症活性升高趋势;选择性TRAP1抑制剂gamitrinib在角质形成细胞、成纤维细胞及化脓性汗腺炎离体皮肤中抑制炎症基因表达,提示TRAP1抑制剂可能作为炎症性皮肤病的局部治疗策略。
要点
- TRAP1敲低显著下调角质形成细胞中IL1B、IL6、IL17C、IL23A、IL36G、CXCL8等多种炎症基因。
- HSP90α与HSP90β选择性及联合敲低呈炎症活性升高趋势。
- TRAP1抑制剂gamitrinib在离体化脓性汗腺炎皮肤中抑制IL1B、IL6、CXCL8、IL17A、IL36G。
核心结论
- HSP90各亚型在皮肤炎症中作用不同,选择性抑制TRAP1具有一致的抗炎效应,可能成为炎症性皮肤病的局部治疗策略。
研究设计与样本
- 在刺激后的角质形成细胞中进行HSP90亚型选择性敲低实验,并以选择性TRAP1抑制剂gamitrinib处理角质形成细胞、成纤维细胞及离体培养的化脓性汗腺炎皮肤。
主要发现
- TRAP1敲低显著下调所测炎症基因(IL1B、IL6、IL17C、IL23A、IL19、IL36G、CXCL8、CCL5、CCL17、CCL20)表达。
- HSP90α和HSP90β选择性及联合敲低呈炎症活性升高趋势。
- GRP94选择性敲低、GRP94+TRAP1联合敲低及4种亚型全部敲低效果不一致。
- gamitrinib抑制角质形成细胞和成纤维细胞中IL17C、IL23A、IL36G表达。
- gamitrinib抑制离体化脓性汗腺炎皮肤中IL1B、IL6、CXCL8、IL17A、IL36G表达。
临床怎么用
- TRAP1抑制剂可能作为炎症性皮肤病的局部外用治疗方向,尚需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HSP90, a molecular chaperone, has been identified as a drug target in inflammatory skin diseases. However, 4 different HSP90 isoforms (HSP90α, HSP90β, GRP94, and TRAP1) exist. Therefore, this study aimed to evaluate the functional role of the HSP90 isoforms in skin inflammation. Selective knockdown of the HSP90 isoforms revealed different inflammatory effects in stimulated keratinocytes. TRAP1 knockdown significantly downregulated the expression of the measured inflammatory genes (IL1B, IL6, IL17C, IL23A, IL19, IL36G, CXCL8, CCL5, CCL17, CCL20). Selective and combined knockdown of HSP90α and HSP90β showed a trend toward increased inflammatory activity. Selective GRP94 knockdown and combined knockdown of the organelle-specific isoforms (GRP94 + TRAP1) or all 4 isoforms resulted in inconsistent effects. In addition, a selective TRAP1 inhibitor (gamitrinib) suppressed the inflammatory gene expression in keratinocytes and fibroblasts (IL17C, IL23A, IL36G) and in hidradenitis suppurativa skin cultured ex vivo (IL1B, IL6, CXCL8, IL17A, IL36G). In conclusion, selective and simultaneous knockdown of the HSP90 isoforms mediated different inflammatory effects, revealing that the HSP90 isoforms have distinct roles in skin inflammation. In addition, we discovered that inhibition of TRAP1 exerted consistent anti-inflammatory effects, suggesting that TRAP1 inhibitors may represent a topical therapeutic strategy for inflammatory skin diseases.
引用
- Ben Abdallah H, Iversen L, Johansen C, et al. The Differential Roles of HSP90 Isoforms in Skin Inflammation: Anti-Inflammatory Potential of TRAP1 Inhibition. J Invest Dermatol. 2025. PMID: 39978584. doi:10.1016/j.jid.2025.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。